Cancer reports (Hoboken, N.J.)

Cancer Rep (Hoboken) · ISSN (e) 2573-8348 · 12 papers in corpus
2026
doi:10.1002/cnr2.70658 ·PMID:42693633

BackgroundOvarian cancer is one of the leading causes of death from gynecological cancer worldwide. Genetic mutations in genes involved in key cellular functions such as BRCA1/2 play a central role in tumorigenesis and have major implicatio…

2026
doi:10.1002/cnr2.70499 ·PMID:41968380

BackgroundGynecological cancers are among the most common cancers in women that affect female reproductive organs. The most common gynecological cancers are ovarian, cervical, uterine/endometrial, vaginal, and vulvar cancer. Women's reprodu…

2026
doi:10.1002/cnr2.70540 ·PMID:41980904

BackgroundEndometrial cancer (EC) is the most common gynaecological malignancy globally, with rising incidence and notable disparities in outcomes. In New Zealand, EC rates have increased significantly, particularly among Māori and Pacific …

2026
doi:10.1002/cnr2.70688 ·PMID:42728640

BackgroundAndrogen deprivation therapy (ADT) is the base of treatment for prostate cancer, and gonadotropin-releasing hormone (GnRH) drugs are given as depot injections. Long-acting formulations may reduce the number of injections and the d…

2025
doi:10.1002/cnr2.70327 ·PMID:40922712

BackgroundThe existing research data cannot fully prove the advantages of single-site Da Vinci robotic surgery (RSS) compared with single-site laparoscopic surgery (LESS) in the treatment of gynecological diseases.AimsTo evaluate the effect…

review 2025
doi:10.1002/cnr2.70388 ·PMID:41152971

INTRODUCTION: Endometrioid borderline ovarian tumor (EBOT) is rare and frequently misdiagnosed. This study aims to investigate the clinicopathological features, immunohistochemical characteristics, differential diagnosis, therapeutic approa…

2025
doi:10.1002/cnr2.70142 ·PMID:40067023

BackgroundOvarian cancer is frequently occurring and fatal for women. CA-125 is important in the screening, diagnosis, and treatment of ovarian cancer. This review study was conducted to explore the influence of CA-125 in addressing ovarian…

2025
doi:10.1002/cnr2.70134 ·PMID:40176545

IntroductionIn developed countries, urologic fistulas arise mainly from malignancies, radiotherapy, or surgical trauma. Hysterectomy and radiation therapy are both critical components of the treatment of women with cancers. Urologic fistula…

2024
doi:10.1002/cnr2.70084 ·PMID:39693204

BackgroundWolffian adnexal tumor is a rare type of tumor that was first discovered and reported by Karim-inejad in 1973. Wolffian adnexal tumor lacks specific clinical manifestations and its histological morphology is similar to various oth…

2024
doi:10.1002/cnr2.70082 ·PMID:39724456

AimsEndometrial cancer (EC) is the most common gynecological cancer worldwide and its incidence is rising. The cornerstone of its management is surgical treatment with nodal staging. A monocentric study investigating the potential of the mo…

2024
doi:10.1002/cnr2.1920 ·PMID:38018319

BackgroundEndometrial adenocarcinoma (EAC) is a malignant tumor of the endometrium. EAC is the most common female malignancy following the menopause period. About 40% of patients with EAC are linked with obesity and interrelated with hypert…

2023
doi:10.1002/cnr2.1875 ·PMID:37503828

BackgroundNeuroblastoma is a common malignant tumor stemming from the sympathetic nervous system in children, which is often life-threatening. The genetics of neuroblastoma remains unclear. Studies have shown that miRNAs participate in the …